It is worth mentioning that TP53 gene, mutated in over half of all human malignancies (31), showed frequent mutation (82.64%) in TNBC in this study, which was concordant with previous research results that TNBC had the highest prevalence of TP53 mutation among all breast cancers (32). This evidence concerns the gene TP53 and breast cancer.